Adagene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.About ADAG
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.
CEOPei Zhi Luo
CEOPei Zhi Luo
Employees138
Employees138
HeadquartersSuzhou, Jiangsu
HeadquartersSuzhou, Jiangsu
Founded2011
Founded2011
Employees138
Employees138
ADAG Key Statistics
Market cap78.71M
Market cap78.71M
Price-Earnings ratio-2.64
Price-Earnings ratio-2.64
Dividend yield—
Dividend yield—
Average volume49.56K
Average volume49.56K
High today$1.67
High today$1.67
Low today$1.67
Low today$1.67
Open price$1.67
Open price$1.67
Volume124.00
Volume124.00
52 Week high$3.16
52 Week high$3.16
52 Week low$1.33
52 Week low$1.33
Stock Snapshot
The current Adagene(ADAG) stock price is $1.67, with a market capitalization of 78.71M. The stock trades at a price-to-earnings (P/E) ratio of -2.64.
On 2025-11-05, Adagene(ADAG) stock traded between a low of $1.67 and a high of $1.67. Shares are currently priced at $1.67, which is 0.0% above the low and 0.0% below the high.
Adagene(ADAG) shares are trading with a volume of 124, against a daily average of 49.56K.
In the last year, Adagene(ADAG) shares hit a 52-week high of $3.16 and a 52-week low of $1.33.
In the last year, Adagene(ADAG) shares hit a 52-week high of $3.16 and a 52-week low of $1.33.